K-number	K223293
Device name	CONTOUR® NEXT GEN Blood Glucose Monitoring System
Applicant	Ascensia Diabetes Care U.S., Inc.
Product code	NBW
Device class	Class II
Decision date	Nov 18, 2022
Decision	Substantially Equivalent
Regulation	862.1345

AI Summary

AI extraction for this record is queued and will appear within 24 hours. View full FDA record →

Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?

Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.

Start free trial →

Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →

CONTOUR® NEXT GEN Blood Glucose Monitoring System

Everything you need for a 510(k) submission. Nothing you don't.